Sosei Appoints David Chiswell as Non-Executive Chairman

21-Mar-2005

Sosei Co. Ltd. announced the appointment of Dr. David Chiswell as Non-Executive Chairman.

David Chiswell was a founder and, from 1996 to 2002, the CEO of Cambridge Antibody Technology (CAT). Currently David is Chairman of the UK's BioIndustry Association (BIA). In addition, he is Chairman of Arrow Therapeutics Ltd and a non-executive director of Arakis Ltd. David is also an advisor to a number of private equity funds including Nomura Phase 4 Ventures. His previous experience was gained with Amersham International as well as within research posts at various institutions including the Medical Research Council, UCLA and the Imperial Cancer Research Fund.

Other news from the department people

Most read news

More news from our other portals

So close that even
molecules turn red...